Tamoxifen is the accepted therapy for sufferers with estrogen receptor- (Er selvf?lgelig)-positive breast cancer. poisonous oxidation products leading to increased survival from tamoxifen-induced oxidative damage. These responses in cancer cells also occur in breast tumors of tamoxifen-treated mice. Additionally, high levels of manifestation of Nrf2, ABCC1, ABCC3 plus NAD(P)H dehydrogenase quinone-1 in breast tumors of… Continue reading Tamoxifen is the accepted therapy for sufferers with estrogen receptor- (Er